LONDON and CARLSBAD, Calif., Dec. 11, 2025 /PRNewswire/ -- DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today ...
When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a new layer of information,” specifically ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback